IntraCrop extends trials programme for 2024
As a science-led organisation, IntraCrop is committed to providing clear evidence of modes of action and ensuring the validity of label claims. It has extended its UK and international trials programme for 2024 to include further commercial and product development trials.
Managing Director, Dr Mark Palmer, tells us, “Scientific trials are the lifeblood of IntraCrop. We want growers to have complete confidence that when they purchase our products, they will deliver the results they expect. We had some impressive data from our 2023 trials. Nutrino Pro was proven to deliver up to 100% nutrient use efficiency; we consolidated Status trials on sugar beet, where previous results recorded an 11 t/ha difference between control and treated plants; and Talisman® delivered on average a 5:1 return on investment. We have a variety of new studies planned for 2024 and we had several trials conclude towards the end of 2023. We look forward to bringing you further information and detailed results as soon as we can.”
Trials of IntraCrop’s existing biostimulant technologies will take place in Great Britain, France, Italy and Spain in 2024 and will include:
- Status on beans, exploring the impact on protein levels
- Status on sugar beet, confirming optimal timing for applications
- Status on herbaceous crops
- Yieldbuilder programme (including Status and Nutrino Pro) on potatoes
Alongside ongoing study of current technologies, trials will also take place on the development of additional uses of these existing products and the launch of new technologies, including:
- UK trials on winter wheat, oilseed rape, herbs and salad and turf grass, looking at optimal sequencing of biostimulants
- Trials in Morocco on winter wheat, sugar beet and tomatoes exploring timings and benefits of biostimulant sequencing
- Trials in Spain on glasshouse tomatoes comparing foliar vs fertigation applications
- Trials in Sweden on spring barley seed treatment
- A laboratory trial at Debrecen University, Hungary, on maize looking at dose response under abiotic stress
- Crop safety trials on a new development product for winter wheat
- A second year of trials in the USA on a range of crops including cotton, maize and peanuts
- A second year of trials in Canada on wheat, canola and maize
Emily Way, IntraCrop’s Technical Officer, returned to the team last year to work on the development of trial design and data analysis. She tells us, “We had such an exciting year last year, with brilliant results in trials for a variety of our biostimulant technologies. As well as this, our patented molecule MTU® received international acclaim when it was presented at the Biostimulants World Congress, so there is a lot of buzz and opportunity around it and our other biostimulants. Already in 2024 we have seen some extreme weather conditions. Technologies such as ours will continue to help address difficult weather events such as these, supporting growers in the maintenance of their yields as conditions become increasingly difficult.”
See our latest news for results from last year’s trials.
8th January 2024
